...
【24h】

Accelerator-based photoproduction of promising beta-emitters Cu-67 and Sc-47

机译:基于加速剂的有希望的β-发射体Cu-67和Sc-47的照相生产

获取原文
获取原文并翻译 | 示例
           

摘要

In this paper we discuss our experimental work in photoproducing two medically-useful radioisotopes (Zn-68(gamma,p) Cu-67 and Ca-48(gamma,n)Ca-47 -> Sc-47) using an electron linear accelerator. We further address the issues of production and separation of medical isotopes arising from photoneutron (gamma,n) and photoproton (gamma,p) reactions. While (gamma,n) reactions typically result in greater yields, separating product nuclides from the target is challenging since the chemical properties of both nuclides are identical. Although the yields of (gamma,p) reactions are typically lower than for (gamma,n), these proton-rich isotopes have the advantage that target and product nuclides belong to different chemical species allowing for more straightforward chemical separation. We conclude the paper by touching upon the dire necessity of experimentally revisiting a broad swath of photonuclear reactions in the 10- to 50-MeV regime. The very paucity of empirical cross-sectional data makes it altogether impossible to realistically predict accelerator-based photoproduction of many promising radiopharmaceuticals.
机译:在本文中,我们讨论了使用电子线性加速器光生两种医学上有用的放射性同位素(Zn-68(γ,p)Cu-67和Ca-48(γ,n)Ca-47-> Sc-47)的实验工作。我们进一步解决了由光中子(γ,n)和光子质子(γ,p)反应产生的医学同位素的生产和分离问题。尽管(γ,n)反应通常会产生更高的收率,但由于两种核素的化学性质相同,因此将产物核素与目标物分离是一项挑战。尽管(γ,p)反应的收率通常低于(γ,n)的收率,但这些富含质子的同位素具有以下优势:目标核素和产物核素属于不同的化学物种,可实现更直接的化学分离。我们通过触及在10至50 MeV范围内实验重新研究广泛的光核反应的迫切必要性来结束本文。经验横断面数据很少,因此完全不可能现实地预测许多有前途的放射性药物的基于促进剂的光产生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号